Preliminary Results of a Phase I Trial Using Preoperative Stereotactic Ablative Breast Radiotherapy (SABER) for Selected Early-Stage Breast Cancer

被引：0
|
作者：
Ogobuiro, I. C. [1 ]
Kesmodel, S. B. [2 ]
Net, J. [3 ]
Reis, I. M. [4 ,5 ]
Takita, C. [1 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Radiat Oncol, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Surg Oncol Div, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Radiol Dept, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Publ Hlth Sci, Miami, FL USA
[5] Univ Miami, Sylvester Biostat Bioinformat Shared Resources BB, Miami, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2715
引用
收藏
页码：E326 / E326
页数：1
相关论文
共 50 条
  • [31] Radiotherapy upregulates the expression of selected immune genes in early-stage breast cancer
    Goma, C.
    Braso-Maristany, F.
    Oses, G.
    Gonzalez-Farre, B.
    Sanfeliu, E.
    Ganau, S.
    Ubeda, B.
    Bargallo, X.
    Prat, A.
    Molla, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S697 - S698
  • [32] Phase I dose escalation trial using single fraction Stereotactic PBI for early stage breast cancer
    Rahimi, A.
    Kim, N.
    Spangler, A.
    Leitch, M.
    Alluri, P.
    Gu, X.
    Ahn, C.
    Goudreau, S.
    Seiler, S.
    Farr, D.
    Wooldridge, R.
    Haley, B.
    Bahrami, S.
    Chen, D.
    Rao, R.
    Timmerman, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S706 - S706
  • [33] Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer
    Mihailo Miljanic
    Chika Nwachukwu
    Assal Rahimi
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 15553 - 15559
  • [34] Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer
    Miljanic, Mihailo
    Nwachukwu, Chika
    Rahimi, Assal
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (17) : 15553 - 15559
  • [35] Response assessment of early-stage breast tumours to stereotactic ablative radiotherapy (SABR) using hybrid PET-MRI imaging
    Kerhoulas, Zoe
    Spears, Melanie
    Brackstone, Muriel
    Lock, Michael
    Thompson, Terry
    Prato, Frank
    Gelman, Neil
    Gaede, Stewart
    Mouawad, Matthew
    MEDICAL PHYSICS, 2021, 48 (08) : 4657 - 4657
  • [36] Preoperative breast MRI in early-stage breast cancer: A decision analysis
    Young, P.
    Kim, B.
    Malin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Early Results of a Prospective Study of Preoperative TumorBed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer
    Jing, H.
    Chen, D.
    Men, K.
    Wang, J.
    Wang, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E314 - E314
  • [38] Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol
    R. K. Charaghvandi
    B. van Asselen
    M. E. P. Philippens
    H. M. Verkooijen
    C. H. van Gils
    P. J. van Diest
    R. M. Pijnappel
    M. G. G. Hobbelink
    A. J. Witkamp
    T. van Dalen
    E. van der Wall
    T. C. van Heijst
    R. Koelemij
    M. van Vulpen
    H. J. G. D. van den Bongard
    BMC Cancer, 17
  • [39] Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol
    Charaghvandi, R. K.
    van Asselen, B.
    Philippens, M. E. P.
    Verkooijen, H. M.
    van Gils, C. H.
    van Diest, P. J.
    Pijnappel, R. M.
    Hobbelink, M. G. G.
    Witkamp, A. J.
    van Dalen, T.
    van der Wall, E.
    van Heijst, T. C.
    Koelemij, R.
    van Vulpen, M.
    van den Bongard, H. J. G. D.
    BMC CANCER, 2017, 17
  • [40] Preoperative PET/CT in early-stage breast cancer
    Bernsdorf, M.
    Berthelsen, A. K.
    Wielenga, V. T.
    Kroman, N.
    Teilum, D.
    Binderup, T.
    Tange, U. B.
    Andersson, M.
    Kjaer, A.
    Loft, A.
    Graff, J.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2277 - 2282
12345